Oorsprong van het eerstegraads netwerk van Thaedra Thullberry
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 29 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Thaedra Thullberry via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Rochester Christian University | College/University | Undergraduate Degree | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Investment Managers | Private Equity Investor Private Equity Investor | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| SEAGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services SillaJen Biotherapeutics, Inc. develops and commercializes cancer therapeutics. It focuses on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for solid tumors. It is focused on two main programs, lead product candidate, which is in mid-stage clinical development for the treatment of advanced primary liver cancer and colorectal cancer and JX-929 which is under investigation for a variety of other solid tumors. The company was founded by John C. Bell and David H. Kirn in 2006 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| ATHIRA PHARMA, INC. | Biotechnology | Chief Executive Officer | |
| Stanford University | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Graduate Degree Doctorate Degree Undergraduate Degree | |
| ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Investor Relations Contact | |
| Santa Clara University | College/University | Masters Business Admin | |
| University of California San Diego | College/University | Undergraduate Degree Graduate Degree | |
| University of California, Santa Cruz | College/University | Undergraduate Degree | |
| University of Stockholm | College/University | Doctorate Degree | |
| MEDIVATION INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Icahn School of Medicine at Mount Sinai | College/University | Doctorate Degree | |
| ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder | |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bayer HealthCare Pharmaceuticals, Inc. manufactures pharmaceutical drugs. It offers pharmaceuticals and therapeutics in the areas of diagnostic imaging, hematology and cardiology, cancer, women's health and several other chronic diseases such as multiple sclerosis and Parkinson's disease. Bayer HealthCare Pharmaceuticals was founded in 1979 and is located in Wayne, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| DNAX Research, Inc. | Corporate Officer/Principal | ||
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| University of Pennsylvania Medical Center | College/University | Doctorate Degree | |
Alpine Bioventures, GP, LLC
 Alpine Bioventures, GP, LLC Investment ManagersFinance Alpine Bioventures, GP, LLC (Alpine Bioventures) is a venture capital firm founded by Mitchell H. Gold in 2013. The firm is headquartered in Seattle, Washington. | Investment Managers | Founder Private Equity Investor Private Equity Investor Private Equity Investor | |
Dendreon Pharmaceuticals, Inc.
 Dendreon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Dendreon Pharmaceuticals, Inc. discovers, develops and commercializes novel products for the treatment of cancer. The company is headquartered in Olympia, WA. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Alpine Bioventures LP
 Alpine Bioventures LP Investment ManagersFinance Alpine Bioventures LP invests in companies located in the United States. The fund targets companies operating in the fields of science and healthcare services. It provides financing for seed and early stage capital requirements. It also makes co-investments. | Investment Managers | Founder | |
| EXICURE, INC. | Biotechnology | Director/Board Member | |
Lumen Bioscience, Inc.
 Lumen Bioscience, Inc. Pharmaceuticals: OtherHealth Technology Lumen Bioscience, Inc. operates as a clinical stage biotechnology company which engages in the manufacture of therapeutic biologics for oral delivery. It focuses on the development of the blue-green algae Spirulina as an industrial scale production platform. The company was founded by Brian Finrow and James Roberts in 2017 and is headquartered in Seattle, WA. | Pharmaceuticals: Other | Director/Board Member | |
ClinOne, Inc.
 ClinOne, Inc. Packaged SoftwareTechnology Services ClinOne, Inc. develops mobile software application. The firm serves for sites and patients. It offers elaerning, screening, documents, videos, econsent, procedure manager, and adverse events services. The company was founded by Rob Bohacs and Eric Schraufnagel and is headquartered in Denver, CO. | Packaged Software | Chairman Director of Finance/CFO | |
Cell Biotherapy, Inc.
 Cell Biotherapy, Inc. BiotechnologyHealth Technology Cell Biotherapy, Inc. develops bio therapeutics. The American company was founded by Michael E. Meyers and he has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| EDGEWISE THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO Founder | |
| JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Zylem Biosciences, Inc. | Biotechnology | Founder | |
| ELICIO THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 47 |
| Verenigd Koninkrijk | 3 |
| Zweden | 2 |
| Nederland | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 4 |
| Technology Services | 2 |
Operationeel
| Director/Board Member | 179 |
| Corporate Officer/Principal | 73 |
| Independent Dir/Board Member | 46 |
| Founder | 32 |
| Chief Tech/Sci/R&D Officer | 31 |
Sterkste connecties
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| James Topper | 49 |
| Peter Thompson | 39 |
| Xiang Ming Cui | 31 |
| Jay Venkatesan | 30 |
| Robert Conway | 21 |
| R. Carruthers | 15 |
| Mitchell Gold | 15 |
| Andrew Sandler | 12 |
| Mark Litton | 11 |
| Christopher Peetz | 11 |
| Wayne Gombotz | 9 |
| Jörn Drappa | 9 |
| Stanford Peng | 9 |
| James Rickey | 8 |
- Beurs
- Insiders
- Thaedra Thullberry
- Bedrijfsconnecties
